Cytokeratin 20 (CK20) and apomucin 1 (MUC1) expression in ampullary carcinoma: Correlation with tumor progression and prognosis
<p>Abstract</p> <p>Background</p> <p>We assessed the expression of cytokeratin (CK) and apomucin (MUC) in ampullary carcinoma (AC) to develop a system for the classification of ACs on the basis of their clinical significance.</p> <p>Method</p> <p>...
Saved in:
Main Authors: | Nishi Takeshi (Author), Inao Touko (Author), Nishisaka Takashi (Author), Tanaka Tsuneo (Author), Kawabata Yasunari (Author), Yano Seiji (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2010-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytokeratin 7 negative and cytokeratin 20 positive orbital metastatic breast carcinoma
by: Sabrina Bergeron, MSc, et al.
Published: (2018) -
Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
by: Jesús K. Yamamoto-Furusho, et al.
Published: (2015) -
Differential expression of CK7, CK20, CDX2 in intestinal and pancreatobiliary types of preriampullary carcinoma
by: Udayagiri D Sree, et al.
Published: (2022) -
The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody
by: Bayrak Reyhan, et al.
Published: (2012) -
Hepatocellular carcinoma: microstructure and expression features of hepatocyte marker, alphafetoprotein, cytokeratins 7 and 20
by: V. A. Tumanskiy, et al.
Published: (2014)